|
Saryeddine, T., Brimacombe, G., Laberge, N., Taylor, D.W., Kumar, R., Arts, K., Bennett, L., Ferdinand, M. 2011.
This document is designed to introduce a conversation. Considering that the focus of the
summit will be on action plan development, the organizers felt it may be helpful and efficient
to summarize commonly known issues and assumptions that will likely underpin the
conversation. In this document, we discuss the value of clinical trials to Canada; what other
countries are doing to attract them; what the situation looks like in our country; possible issues
and explanations for recent trends; an overview of our strengths, and a look at current
initiatives at both the national and provincial levels. |
|
Read more...
|
|
|
Immunobiology Vandana Gambhir, Julia Kim, Sarah Siddiqui, Michelle Taylor, Valarie Byford, Elaine O. Petrof, Glenville Jones, Sameh Basta The vitamin D metabolite, 1,25-(OH)2D3, binds the vitamin D receptor(VDR) to exert its regulatory effects at the transcription level. VDR is expressed in professional antigen-presenting cells (pAPCs), such as macrophages (Mø) and dendritic cells (DCs). We show for the first time that the 24-hydroxylase enzyme is activated in bone marrow-derived dendritic cell (BMDC), due to 1,25(OH)2D3 stimulation which resulted in the induction of its gene, CYP24A1. |
|
Read more...
|
|
Robert Freeman, Ph.D., Kristina M. Lybecker, Ph.D., D. Wayne Taylor, Ph.D., F.CIM Executive Summary In the midst of rising health care expenditures, increasingly limited health care budgets and economic uncertainty, the efficient use of government funds and other resources is of the utmost importance. In March 2010, the Patient Protection and Affordable Care Act (ACA) expanded Medicaid, to help reduce the number of uninsured, thus potentially further increasing tremendously the fiscal burden on the states. According to the Office of the Actuary of the Centers for Medicare and Medicaid Services the states’ Medicaid programs spending is forecast to increase by an annual rate of 8.4% from 2009 to 2019. Some of the cost increase is due to the inefficiencies inherent in the highly fragmented nature of the delivery of Medicaid between state and private enterprise, between stand-alone and co-ordinated services models, between individual and population health management strategies, and among the 50 states themselves. |
|
Read more...
|
|
There is an old saying in
political science, “if you change the language, you change the debate.” This has happened in Canada. Everyone is told, and most believe,
that the number one driver of healthcare costs is drugs. This is just not true. The number one driver of healthcare
costs is our health. Spending on
drugs is a good thing. We are very
lucky that medical therapies multiplied in number just as we were closing 36%
of our hospital beds across Canada in the 1990’s. |
|
Read more...
|
|
Healthcare Management Forum Michael Heenan, MBA, CPHQ; Brady Wood, MA; D. Wayne Taylor, PhD, FCIM
In the words of one hospital manager, “hospital data is currently indigestible and alien to the average user.” Drawing upon the experience of an academic hospital that, contrary to established practice, published real numbers alongside rates and ratios during a Clostridium difficile outbreak, the authors examined the pitfalls of publishing only abstract performance measures and the advantages of releasing real numbers to the public. This article identifies lessons for hospital board governance, media relations, employee communications, and citizen and patient engagement that are applicable across the healthcare industry in many countries. If healthcare is to be a caring industry, then care should be taken in the public reporting of data and information.
|
|
Read more...
|
|
|
|
|
<< Start < Prev 1 2 3 4 5 Next > End >>
|
|
Page 2 of 5 |